Home › What Pharma/Biotech Investors Need To Know About Adaptive Trials
 

Keywords :   


What Pharma/Biotech Investors Need To Know About Adaptive Trials

2016-01-16 19:10:13| Biotech - Topix.net

The FDA allows for adaptive drug trials during which key protocols may be altered during the course of the trial depending on interim results. Investors concerned with pharmaceutical or biotech drug development, from early to late stages, need to be aware of the benefits and risks of adaptive trials because their use and interpretation can impact corporate valuations.

Tags: investors trials adaptive pharmabiotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.06KDV Label names Gary Morrison SVP sales and marketing
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Public Advisory Number 4A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Atlantic Tropical Weather Outlook
18.06Eastern North Pacific Tropical Weather Outlook
18.06CCAI Recognizes 2024 Award Recipients
18.06German court dismisses anti-competitive claims against Tageos
More »